Ginkgo biloba treatment of 48 patients with chronic schizophrenia _4999

[wlsqfjaru]

Ginkgo biloba treatment of 48 patients with chronic schizophrenia
 
 
Months, no change in patients with the disease. Male 64 cases, 30 females, aged 22 to 67 years, mean (plus .4 ± 9.6) years, duration of 4-30a, the average (15.4 ± 9.9) a. Randomly divided into treatment group (Ginkgo biloba group) 48 cases and the control group of 46 patients, two groups in age, duration of disease, recurrence, etc. are not significant. 1.2 in the original treatment group on the basis of antipsychotic treatment (clozapine or sulpiride 100 ~ 400d 200-600mg / d or more beneficial than five fluorine 20 60 weeks), the use of Ginkgo biloba treatment, the amount of 40rag 1 week , delete the first 2 weeks 8Orag, tid, the maximum amount of 120rag,You are not allowed to view links. Register or Login, lid were treated for 8 weeks, treatment is prohibited to change the original type and dosage of antipsychotics with conventional drug therapy group. 1.3 The evaluation standard by Brief Psychiatric Rating Scale (BPRS), Scale for Assessment of Negative Symptoms (SANS) and the side effects of antipsychotics Scale (TESS) assess changes in symptoms and side effects situation. All scale chosen by the clinical psychiatrist evaluated. And in patients before treatment, 2 weeks, 4 weeks, 8 weeks of the assessment 1. Rater consistency of these tests reached the required scale. According to SANS clinical reduction rate before and after treatment to determine: reduction rate> 50% markedly effective, 25% a 50% effective, before and after the clinical score of BPRS and SANS is shown in table 1. bad a reserve amount of the two groups before treatment failure rates when compared ± s Ho Lai-treatment control groups Note: Hao treatment group before and after P  0.05). After 8 weeks of treatment, BPRS and SANS treatment group scores were significantly lower compared with the control group before treatment by group , after the SANS fraction was 43.2% less, according to clinical evaluation standard is valid. This group Ginkgo 120 ~ 36Ofnd, 8 weeks no significant side effects, TESS score before treatment was 10.9 ± 5.2, 8 weeks to 9.7 ± 4.7, the difference was not significant (P> 0.05). 3 to discuss the current studies suggest that mainly negative symptoms of schizophrenia may be associated with brain atrophy in patients with temporal lobe dysfunction,You are not allowed to view links. Register or Login, blood flow reduced glucose metabolism and reduce oxygen consumption, central neurotransmitter and receptor dysfunction and free radicals in pathological processes related to .... ginkgo biloba extract can improve energy metabolism in the central nervous system, and enhance the environment in poor ability to adapt to 2J. The extract in addition to improve the heart, cerebral microcirculation, there are changes in scavenging free radicals and the role of neurotransmitters,You are not allowed to view links. Register or Login, is a powerful antioxidant, can remove the body produces too much when the oxidative metabolism The superoxide radical J. ginkgo biloba extract activated by NNPA glutamate receptor, can enhance memory and improve cognitive function. This paper shows that the original basis of antipsychotic medication combined Ginkgo biloba, on effect of negative symptoms of schizophrenia was significantly better than antipsychotics alone, a result consistent with the literature reported. Tip: Ginkgo to improve cerebral blood flow, while antipsychotics may be associated with increased blood in the brain concentration. 'BIBLIOGRAP 1 Yangshun Wu. Ginkgo biloba on the role of negative symptoms of schizophrenia. Clinical Psychological Medicine, 1998,8 (3): 148 ~ 1492 glenoid where the strong. Shuxuening treatment of 36 patients with chronic schizophrenic dual blind controlled study Journal of Clinical Psychiatry, 1996,6 (6): 3393 Lo Air spring Shuxuening combined treatment of chronic schizophrenic psychiatric drugs treatment and education of clinical analysis. Journal of Psychiatry,You are not allowed to view links. Register or Login, 1996,29 (1): 314 Stone Admiralty. Shu Xue Ning combined treatment of chronic schizophrenic double-blind controlled study. Clinical Psychological Medicine, 1996,6 (6): 338 [Introduction】 Fan of hot metal cylinder M, 52 years old, the attending physician. Jiujiang City Fifth People's Hospital of Psychiatry ( 332OO0), in the psychiatric treatment of refractory schizophrenia research, published 6. Konghai Zhen Female,You are not allowed to view links. Register or Login, 45 years old, the attending physician. Jiujiang shake the spirit of the Fifth People's Hospital (study, published on the Ge 3. Huang Ping, male, 34 years old, the doctor. Jiujiang City Fifth People's Hospital of Psychiatry (332OOO) in the brain matter of huge mental obstacle Zhang, Ru published 7. (1999434-20 Received) I